Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators
Deborah B Doroshow, Ticiana A Leal, Saiama N Waqar, et al.
European Urology
|
August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial
Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2015
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S Herbst, David R Gandara, Fred R Hirsch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 26, 2016
Scientific Advances in Lung Cancer 2015
Anne S Tsao, Giorgio V Scagliotti, Paul A Bunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 1, 2018
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
Gideon M Blumenthal, Paul A Bunn, Jamie E Chaft, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators
Deborah B Doroshow, Ticiana A Leal, Saiama N Waqar, et al.
European Urology
|
August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial
Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2015
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S Herbst, David R Gandara, Fred R Hirsch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 26, 2016
Scientific Advances in Lung Cancer 2015
Anne S Tsao, Giorgio V Scagliotti, Paul A Bunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2024
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 1, 2018
Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
Gideon M Blumenthal, Paul A Bunn, Jamie E Chaft, et al.
Page
of 9